首页 | 本学科首页   官方微博 | 高级检索  
     

地高辛血药浓度超出安全限值风险预测模型的建立与评估
引用本文:李晶,段自皞,沈炳香,何春远,王法财,聂松柳. 地高辛血药浓度超出安全限值风险预测模型的建立与评估[J]. 中国医院药学杂志, 2021, 41(13): 1332-1336. DOI: 10.13286/j.1001-5213.2021.13.11
作者姓名:李晶  段自皞  沈炳香  何春远  王法财  聂松柳
作者单位:安徽医科大学附属六安医院/六安市人民医院药学部, 安徽 六安 237005
基金项目:安徽医科大学校科学研究基金资助项目(编号:2019xkj220)
摘    要:目的:探讨地高辛血药浓度超出安全限值(2.0 ng·mL-1)的影响因素并构建相关风险预测模型,为地高辛的安全合理用药提供参考.方法:回顾性分析2019年1月至2020年12月安徽医科大学附属六安医院服用地高辛进行治疗并接受血药浓度监测的153例住院患者的临床资料,将所纳入患者按地高辛血药浓度监测值分为达标组(0.5 ...

关 键 词:地高辛  血药浓度  治疗窗  影响因素  风险预测模型
收稿时间:2020-12-22

Establishment and evaluations of risk prediction model of digoxin blood concentration exceeding a safe limit
LI Jing,DUAN Zi-hao,SHEN Bing-xiang,HE Chun-yuan,WANG Fa-cai,NIE Song-liu. Establishment and evaluations of risk prediction model of digoxin blood concentration exceeding a safe limit[J]. Chinese Journal of Hospital Pharmacy, 2021, 41(13): 1332-1336. DOI: 10.13286/j.1001-5213.2021.13.11
Authors:LI Jing  DUAN Zi-hao  SHEN Bing-xiang  HE Chun-yuan  WANG Fa-cai  NIE Song-liu
Affiliation:Department of Pharmacy, Affiliated Lu'an Hospital, Anhui Medical University, Lu'an People's Hospital, Anhui Lu'an 237005, China
Abstract:OBJECTIVE To explore the influencing factors of digoxin blood concentration exceeding a safe limit and establish a risk prediction model to provide reference for safe and rational dosing of digoxin.METHODS Clinical data were retrospectively reviewed for 153 patients on digoxin therapy and blood concentration was monitored from January 2019 to December 2020. They were divided into goal-attaining group (0.5 ng·mL-1≤blood concentration≤2.0 ng·mL-1) and over-limit group (blood concentration >2.0 ng·mL-1) according to the levels of blood digoxin concentration. Gender, age, body mass index (BMI), kidney damage, daily dose and combined drug dosing of two groups were screened by Logistic regression analysis for independent influencing factors of blood digoxin concentration exceeding a safe limit. A nomogram prediction model was established on the basis of screened independent influencing factors.RESULTS Gender (OR=0.379, 95%CI: 0.244-0.589), kidney damage (OR=0.252, 95%CI:0.162-0.391), daily dose (OR=0.438, 95%CI:0.279-0.689), combination of gastroprokinetic agents (OR=1.975, 95%CI:1.294-3.013), combination of antibiotics (OR=0.471, 95%CI:0.299-0.741), combination of β-receptor blockers (OR=0.454, 95%CI:0.277-0.642) and Qili Qiangxin capsule (OR=0.096, 95%CI:0.026-0.353) were independent influencing factors of blood digoxin concentration exceeding a safe limit. Based upon seven independent influencing factors, a nomogram prediction model for blood digoxin concentration exceeding a safe limit was established. C-index of the model was 0.742, indicating that the nomogram model had a decent discrimination. The validation of the model showed that the predicted and observed values were basically consistent, indicating that the nomogram prediction model had a decent consistency.CONCLUSION The nomogram model based upon independent influencing factors has showed excellent discrimination and consistency. With clinical value in screening patients with a high risk of blood digoxin concentration exceeding a safe limit, it is of great significance to prepare treatment protocols for these patients.
Keywords:digoxin  blood drug concentration  therapeutic window  influencing factors  risk prediction model  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号